Publication | Open Access
WITHDRAWN: SGLT2i reduces renal injury by improving mitochondrial metabolism and biogenesis
14
Citations
29
References
2022
Year
Canagliflozin could be used to treat septic AKI by activating the AMPKα1/PGC1α/NRF1/mitochondrial biogenesis pathway.
| Year | Citations | |
|---|---|---|
Page 1
Page 1